Autosomal dominant hypocalcemia 1
MONDO:0011013Any autosomal dominant hypocalcemia in which the cause of the disease is a mutation in the CASR gene.
Also known as: hypocalcemia, autosomal dominant, CASR autosomal dominant hypocalcemia, HYPOC1, autosomal dominant hypocalcemia caused by mutation in CASR, autosomal dominant hypocalcemia type 1, hypocalcemia, autosomal dominant type 1, hypocalcemia, autosomal dominant, with Bartter syndrome, hypercalciuric hypocalcemia
7 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New hope for kids with rare calcium disease: encaleret trial launches
Disease control Recruiting nowThis study tests a drug called encaleret in 28 children (birth to 17 years) with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic condition causing low blood calcium. The goal is to see if the drug can safely raise calcium levels and reduce urinary calcium loss. Part…
Phase: PHASE2, PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
NIH launches major study to unlock secrets of rare bone diseases
Knowledge-focused Recruiting nowThis study aims to collect information and bone samples from up to 1,000 people with bone or mineral disorders, such as tumor-induced osteomalacia or familial tumoral calcinosis. Participants receive standard medical evaluations and may provide bone tissue from surgery or a biops…
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Aug 18, 2026 04:00 UTC